Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development perks.

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

MIAMI, FL / ACCESS Newswire / June 25, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a ...

Patients with migraine with aura show reduced migraine symptoms, less rescue medication use, and more sustained pain relief ...

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

Central nervous system; Peripheral nervous system; Systemic vasculitis; Connective tissue diseases; ... associated to infectious, malignant and connective tissue diseases (Chart 1). The latter cover a ...

Global Phase 2b PRIZM Study of Zagociguat is Currently Enrolling Participants with MELASCAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the U.S. Food and ...

STOCKHOLM, SE / ACCESS Newswire / June 12, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...

Chinese scientists have, for the first time, confirmed the existence of microglia in the peripheral nervous system (PNS). This breakthrough provides novel insights into PNS development, opening ...

Reference: Wu Z, Wang Y, Chen W wei, et al. Peripheral nervous system microglia-like cells regulate neuronal soma size throughout evolution. Cell. 2025. doi: 10.1016/j.cell.2025.02.007. This article ...

SHENZHEN, April 7 (Xinhua) -- Chinese scientists have, for the first time, confirmed the existence of microglia in the peripheral nervous system (PNS). This breakthrough provides novel insights ...